FDA VRBPAC Recommends COVID-19 Vaccine Protection for JN1 Variant - Contagion Live

Retrieved on: 2024-06-06 23:36:38

Tags for this article:

COVID-19 vaccination in the United States

RNA vaccines

JN1

Novavax

COVID-19 vaccine

Click the tags to see associated articles and topics

FDA VRBPAC Recommends COVID-19 Vaccine Protection for JN1 Variant - Contagion Live. View article details on hiswai:

Excerpt

“Novavax's JN1 COVID-19 vaccine has demonstrated broad cross-neutralizing antibodies for a range of JN1 descendant viruses, including KP2 and KP3. We ...

Article found on: www.contagionlive.com

View Original Article